(1)
Cortesi, P. A.; Paolicelli, D.; Capobianco, M.; Cozzolino, P.; Mantovani, L. G. The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis. FE 2019, 20.